February 16, 2016February 16, 2016

Ulcerative Colitis Patients Resistant to Treatment May Find Golimumab a Viable Therapeutic Option

Golimumab (symponi) is the latest addition to TNF-α blocking drugs for inflammatory bowel diseases (IBD) such as ulcerative colitis (UC). A summary of all available safety and efficacy data on the ... Read more

August 19, 2015August 19, 2015

Thalidomide Helps Refractory UC Patients Achieve and Maintain Remission

News, Ulcerative colitis

Results from an 8-week clinical trial coupled with an 8-week trial extension show evidence that children with refractory ulcerative colitis (UC) can achieve and maintain remission when treated with the ... Read more